| Bethany V Savage, OTR/L | |
|
5144 Sandpiper Ct, Grove City, OH 43123-8077 | |
| (614) 406-0016 | |
| Not Available |
| Full Name | Bethany V Savage |
|---|---|
| Gender | Female |
| Speciality | Occupational Therapist |
| Location | 5144 Sandpiper Ct, Grove City, Ohio |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1568707867 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225X00000X | Occupational Therapist | 007057 (Ohio) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Bethany V Savage, OTR/L 5144 Sandpiper Ct, Grove City, OH 43123-8077 Ph: (614) 406-0016 | Bethany V Savage, OTR/L 5144 Sandpiper Ct, Grove City, OH 43123-8077 Ph: (614) 406-0016 |
News Archive
A new study from the Stanford Cancer Institute finds that young women who are treated with chemotherapy for breast cancer but have residual tumor in either the breast or lymph nodes have higher chances of recurrence compared to those with no evidence of any residual invasive tumor (pathologic complete response).
Researchers at the Hebrew university of Jerusalem have created a molecule that could potentially lower diabetic patients' higher risk of developing dementia or Alzheimer's disease.
Sirnaomics, Inc. announced today that the company has been awarded another NIH SBIR grant for developing its small interfering RNA (siRNA) therapeutic product STP705 to improve skin wound healing with minimized scar formation.
Celgene International Sàrl announced that clinical data from two studies evaluating the use of REVLIMID® (lenalidomide) with standard R-CHOP chemotherapy in patients with untreated diffuse large B cell (DLBCL) or grade 3 follicular lymphoma were presented at the 11th International Conference on Malignant Lymphoma in Lugano, Switzerland.
Researchers led by Drs. Lillian Maggio-Price and Brian Iritani at The University of Washington found that mice that lack the immune inhibitory molecule Smad3 are acutely sensitive to both bacterially-induced inflammation and cancer.
› Verified 6 days ago
Heather Ann Biro, Occupational Therapist Medicare: Accepting Medicare Assignments Practice Location: 2030 Stringtown Rd Ste 310, Grove City, OH 43123 Phone: 614-782-8718 | |
Josh Evans, OTR/L Occupational Therapist Medicare: Medicare Enrolled Practice Location: 40 Ryan Ln, Grove City, OH 43123 Phone: 740-352-2502 | |
Mary Holcomb, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 3805 Marlane Dr, Grove City, OH 43123 Phone: 614-801-3000 | |
Kristen Bach, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 3805 Marlane Dr, Grove City, OH 43123 Phone: 614-801-3000 | |
Establishing Roots Therapy Llc Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 4152 Patzer Ave, Grove City, OH 43123 Phone: 614-406-2727 | |
Megan Clouse, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 4380 Shirlene Ct, Grove City, OH 43123 Phone: 740-505-4330 | |
Ms. Susan Colborn, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 4324 Haughn Road, South Western Education Preschool Center - Tuesday & We, Grove City, OH 43123 Phone: 614-801-8448 |